- Home
- PRPO vs KLTO Comparison
PRPO vs KLTO Comparison
Compare PRPO & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- KLTO
- Stock Information
- Founded
- PRPO N/A
- KLTO 2019
- Country
- PRPO United States
- KLTO United States
- Employees
- PRPO N/A
- KLTO N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- KLTO
- Sector
- PRPO Industrials
- KLTO
- Exchange
- PRPO Nasdaq
- KLTO NYSE
- Market Cap
- PRPO 9.5M
- KLTO 7.6M
- IPO Year
- PRPO N/A
- KLTO N/A
- Fundamental
- Price
- PRPO $6.25
- KLTO $0.30
- Analyst Decision
- PRPO
- KLTO
- Analyst Count
- PRPO 0
- KLTO 0
- Target Price
- PRPO N/A
- KLTO N/A
- AVG Volume (30 Days)
- PRPO 7.5K
- KLTO 228.8K
- Earning Date
- PRPO 11-06-2024
- KLTO 11-26-2024
- Dividend Yield
- PRPO N/A
- KLTO N/A
- EPS Growth
- PRPO N/A
- KLTO N/A
- EPS
- PRPO N/A
- KLTO N/A
- Revenue
- PRPO $17,411,000.00
- KLTO N/A
- Revenue This Year
- PRPO $75.18
- KLTO N/A
- Revenue Next Year
- PRPO N/A
- KLTO N/A
- P/E Ratio
- PRPO N/A
- KLTO N/A
- Revenue Growth
- PRPO 31.31
- KLTO N/A
- 52 Week Low
- PRPO $4.31
- KLTO $0.26
- 52 Week High
- PRPO $8.49
- KLTO $13.10
- Technical
- Relative Strength Index (RSI)
- PRPO 52.41
- KLTO N/A
- Support Level
- PRPO $6.14
- KLTO N/A
- Resistance Level
- PRPO $6.47
- KLTO N/A
- Average True Range (ATR)
- PRPO 0.19
- KLTO 0.00
- MACD
- PRPO 0.01
- KLTO 0.00
- Stochastic Oscillator
- PRPO 88.00
- KLTO 0.00
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.